Assessing the Clinical Efficacy of Therapeutic Drug Monitoring for Risperidone and Paliperidone in Patients with Schizophrenia: Insights from a Clinical Data Warehouse.

Pharmaceuticals (Basel) · 2024 · PMC11280477 · PMID 39065735

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may not be significantno p-value reported

Unlike risperidone, the clinical relevance of being a CYP2D6 poor metabolizer may not be significant for paliperidone treatment.

also in 2,774 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.